Raman, Jaishree
Allen, Elizabeth
Workman, Lesley
Mabuza, Aaron
Swanepoel, Hendrik
Malatje, Gillian
Frean, John
Wiesner, Lubbe
Barnes, Karen I. http://orcid.org/0000-0002-0107-3063
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial
https://doi.org/10.1186/s12936-019-2841-8
Funding for this research was provided by:
South African Medical Research Council
Article History
Received: 31 January 2019
Accepted: 17 June 2019
First Online: 24 June 2019
Ethics approval and consent to participate
: Approval for this study was obtained from the South African Health Products Regulatory Authority (20151033) and the ethics committees of Mpumalanga Provincial Department of Health (MP_2016RP52_878) and the Universities of Cape Town (737/2015), Pretoria (85/2018) and Witwatersrand (M151129).This trial was registered as PACTR201611001859416 with the Pan African Clinical Trial Registry on 11 November 2016 (ExternalRef removed).All participants and parents/guardians/caregivers of participants < 18 years of age provided written informed consent, prior to enrolment. Assent was obtained from participant aged between 7 and 18 years.
: Not applicable.
: The authors declare that they have no competing interests.